The Cardio Group, LLC (TCG) was founded in 2009. The goal was to find a device that would assist healthcare practitioners in addressing the cardiovascular needs of their patients through the use of a non-invasive, real time, plethysmograph or cardio pulsewave analyzer. The reason being is that cardiovascular disease is the number one killer in North America and TCG wanted to arm the practitioners with a cost effective device so that every patient could be screened.
At the time, and even true today, many of the competitor’s devices were and are too costly, too temperamental or the companies provide poor support. As a result, TCG has secured the exclusive rights for United States, Canada, and Mexico for the Max Pulse screening device. The Max Pulse uses cutting-edge technology, it is economical, portable, user friendly, and non-invasive and is ideal for screening cardiovascular health in patients.
In the past two years, TCG has sold hundreds of devices into the medical, chiropractic, and naturopathic offices across the licensed territories. Patient’s lives have been extended through early detection and the use of quality courses of therapy prescribed by their healthcare practitioners.
In the end, the mission of TCG is to save lives, one heartbeat at a time. TCG does this by providing primary care providers with the knowledge, tools and systems to detect cardiovascular problems early, then measure the effectiveness of their prescribed course of therapy.
